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Toxic substances and microbial or food-derived antigens continuously challenge the 
liver, which is tasked with their safe neutralization. This vital organ is also important for 
the removal of apoptotic immune cells during inflammation and has been previously 
described as a “graveyard” for dying lymphocytes. The clearance of apoptotic and 
necrotic cells is known as efferocytosis and is a critical liver function to maintain tissue 
homeostasis. Much of the research into this form of immunological control has focused 
on Kupffer cells, the liver-resident macrophages. However, hepatocytes (and other liver 
resident cells) are competent efferocytes and comprise 80% of the liver mass. Little is 
known regarding the mechanisms of apoptotic and necrotic cell capture by epithelia, 
which lack key receptors that mediate phagocytosis in macrophages. Herein, we dis-
cuss recent developments that increased our understanding of efferocytosis in tissues, 
with a special focus on the liver parenchyma. We discuss the impact of efferocytosis in 
health and in inflammation, highlighting the role of phagocytic epithelia.
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KeY POiNTS
•	 Efferocytosis	is	a	vital	process	in	tissues	that	can	be	carried	out	by	multiple	cell	types,	including	
blood	derived	and	tissue	resident	phagocytes.
•	 Hepatocytes	are	competent	efferocytes	and	play	an	important	role	in	the	clearance	of	dead	cells	in	
health	and	in	inflammation.
•	 Epithelial	 cell	 efferocytosis	 is	 understudied	 and	 involves	 distinct	 mechanisms	 to	 professional	
phagocytes.
•	 Defects	 in	 efferocytosis	have	been	 linked	 to	diseases	 such	as	 autoimmunity,	 failure	 to	prevent	
metastasis,	failure	to	limit	infection.
•	 Understanding	molecular	mechanisms	of	efferocytosis	may	reveal	new	pathways	for	therapeutic	
intervention	to	alleviate	inflammation.
eFFeROCYTOSiS iN THe LiveR
Efferocytosis,	the	clearance	of	dead	and	dying	cells,	 is	 important	to	prevent	tissue	damage	and	
promote	 the	 resolution	 of	 inflammation	 (1).	The	 liver	 has	 evolved	 into	 an	 expert	 in	 defusing	
biochemical	threats	emanating	from	food	or	microbial	antigens,	which	reach	the	organ	along	with	
75%	of	its	blood	supply	that	arrives	through	venous	blood	from	the	gut.	Hepatocytes	comprise	
FiguRe 1 | Organization of liver-resident and recirculating efferocytes.  
(A) Hepatocytes are spread over three zones, exposed to different levels  
of oxygen and nutrients. Hepatocytes in zone 1 proximal to the portal triad 
(portal vein, hepatic artery, bile duct) have access to arterial and venous 
blood entering the liver through the circulation. Hepatocytes in zone 3 have 
less access to oxygen and nutrients and are exposed to blood draining into 
the central vein. Hematoxylin-eosin stain, scale bar represents 50 µm. (B) A 
plethora of liver resident and recirculating cells are able to engulf apoptotic 
and necrotic cells and clear them to maintain tissue homeostasis. Kupffer 
cells, monocytes and macrophages (mϕ) are the best-characterized 
efferocytes in the liver.
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80%	of	liver	cells	and	constitute	the	biochemical	powerhouses	
of	 the	 liver	 parenchyma,	 and	 as	 a	 result	 they	 often	 perish	 in	
their	 duties	 to	 absorb	 toxic	 substances.	 To	 cope	 with	 loss	 of	
hepatic	 epithelia,	 the	 liver	has	 evolved	 the	 remarkable	 ability	
to	regenerate.
To	perform	their	detoxification	roles,	hepatocytes	are	stra-
tegically	 organized	 roughly	 into	 two	 hepatocyte-thick	 cords,	
flanked	 by	 a	 thin	 layer	 of	 fenestrated	 endothelia	 (Figure  1).	
Nutrient-rich	 blood	 enters	 the	 liver	 via	 the	 portal	 vein	 and	
oxygen-rich	blood	via	the	hepatic	artery,	which,	together	with	
a	bile	duct,	form	the	liver	portal	triad	(Figure 1A).	Blood	from	
both	sources	mixes	in	the	specialized	hepatic	capillaries	termed	
sinusoids,	 and	 drains	 toward	 the	 central	 vein.	 Hepatocytes	
near	the	portal	triads	(designated	zone	1)	can	be	damaged	by	
the	 inflammatory	 infiltrate	 during	 interface	 hepatitis,	 when	
immune	 cells	 cross	 the	 sinusoidal	 endothelia	 and	 reach	 the	
parenchyma.	Zone	2	is	found	mid-distance	from	a	portal	triad	
and	the	draining	central	vein	(zone	3).	Periportal	hepatocytes	
near	zone	1	have	access	to	oxygenated	blood	from	the	hepatic	
artery,	and	nutrients	from	the	portal	blood	supply	that	arrives	
from	 the	 gut.	 Oxygen	 and	 nutrient	 levels	 reduce	 toward	 the	
central	 vein	 and	 hepatocytes	 in	 zone	 3	 are	 found	 in	 hypoxic	
conditions.	 Fenestrations	 in	 the	 sinusoids	 allow	 hepatocytes	
access	 to	solutes	and	 immune	cells	reaching	through	the	 fen-
estrations	from	the	circulation	(2,	3),	but	prevent	unregulated	
migration	of	immune	cells	to	the	parenchyma	(4).
Cells	that	perish	in	the	sinusoidal	spaces	are	cleared	by	cir-
culating	phagocytes	(monocytes,	dendritic	cells,	neutrophils),	
liver-resident	macrophages	termed	Kupffer	cells,	and	by	sinu-
soidal	 endothelia	 (Figure  1B).	 The	 best-characterized	 liver	
efferocytes	are	macrophages,	both	those	derived	from	mono-
cytes	 infiltrating	 from	the	circulation,	and	 the	 self-renewing	
populations	of	Kupffer	cells.	It	is	understood	that	professional	
phagocytes	are	activated	during	injury	and	adapt	their	pheno-
type	following	the	encounter	of	cellular	debris,	danger	signals,	
and	soluble	mediators	of	the	inflammatory	milieu.	The	critical	
role	 of	 liver	macrophages	 including	Kupffer	 cells	 in	 the	 ebb	
and	 flow	 of	 inflammation	 was	 recently	 reviewed	 by	 Tacke’s	
group	(5,	6).
Activated	 hepatic	 stellate	 cells	 can	 also	 engulf	 apoptotic	
hepatocytes,	which	in	turn	lead	to	increases	in	tumor	growth	
factor-β	 (TGF-β)	 secretion	 (7).	Biliary	 epithelial	 cells	 (BECs)	
also	 take	part	 in	 efferocytosis	 of	 neighboring	 apoptotic	 cells;	
an	important	adaptation	for	diseases	associated	with	increased	
BEC	 apoptosis	 such	 as	 primary	 biliary	 cholangitis	 (8).	 The	
phagocytic	 activity	 of	 hepatocytes	 was	 noted	 in	 1992	 (9).	
Hepatocyte	 efferocytosis	 assists	 in	 parenchymal	 housekeep-
ing	 to	 rapidly	dispose	of	cell	 remnants	and	prevent	excessive	
inflammation.
Hepatocyte	 death	 from	 biochemical	 toxicity	 (necrosis)	
occurs	 in	 health	 as	 part	 of	 normal	 homeostasis,	 however,	
liver	damage	 is	 exacerbated	 in	 infection	or	 in	 alcoholic,	 drug	
or	 ischemia-induced	liver	 injury	where	 large	areas	of	necrotic	
lesions	 are	 evident	 (Figure  2).	 Acute-on-chronic	 liver	 failure	
is	 a	 syndrome	 associated	 with	 exacerbation	 of	 hepatitis	 B	
infection	 (HBV)	 and	 characterized	 by	 broad	 areas	 of	 hepatic	
necrosis	in	cirrhotic	patients	(Figure 2A).	Lymphocyte	infiltra-
tion	is	often	seen	in	the	parenchyma	in	chronic	liver	diseases.	
Crispe	 and	 others	 have	 elegantly	 put	 forward	 the	 “graveyard	
theory”	 where	 the	 liver	 is	 primary	 site	 for	 the	 disposal	 of	
spent	 immune	 cells	 (10).	 Figure  2B	 shows	 hepatic	 epithelia	
in	 the	 process	 of	 engulfing	 immune	 cells	 that	 have	 perished	
in	 the	 parenchyma,	 and	 this	 is	 seen	 predominantly	 near	 the	
portal	 regions.	Conversely,	 in	 cases	 of	 acute	 liver	 injury	 such	
as	 paracetamol	 overdose	 (POD),	 hepatocyte	 necrosis	 due	 to	
loss	of	ATP	is	noted	around	the	centrilobular	regions	(zone	3,	
Figure 2C).	Histological	features	of	necrotic	hepatocytes	include	
eosinophilic	degradation	and	pyknotic	nuclei,	which	are	readily	
detectable	by	hematoxylin-eosin	staining	(inset,	Figure 2C).
Hepatocytes	also	clear	away	cells	that	have	triggered	the	mole-
cular	 cascade	 of	 events	 of	 programmed	 cell	 death	 (apoptosis)	
(Figures 2B,D),	but	can	actively	destroy	live	autoreactive	immune	
cells	by	direct	engulfment	as	noted	for	CD8+	T cells	undergoing	
suicidal emperipolesis	 (11).	 Immune	 cell	 death	 and	 liver	 dam-
age	 are	 exacerbated	 in	 chronic	 liver	 inflammation	 of	 multiple	
FiguRe 2 | Hepatocytes engulf necrotic and apoptotic cells in acute-on-chronic liver injury caused by hepatitis B infection (HBV) and in paracetamol injury (POD). 
(A) Hematoxylin–eosin staining of acute-on-chronic liver injury in a patient with HBV infection. Large areas of hepatocyte necrosis are evident. Inset image shows 
dark stained hepatocyte nuclei in live hepatocytes (L) and pyknotic or karyolytic nuclei in necrotic hepatocytes (N). (B) Healthy hepatocytes with clearly marked 
nuclei are seen phagocytosing small apoptotic cells (arrows). Note hepatocyte invaginations which have formed to enable capture of apoptotic cells.  
(C) Hematoxylin-eosin staining of liver with paracetamol-induced injury, which causes centrilobular necrosis. Inset shows pink cytoplasm in necrotic hepatocytes  
(N) compared to surviving non-discolored hepatocytes with clearly defined nuclei (L). (D) In situ end labeling (ISEL) of apoptotic cell nuclei is seen here in pink, in  
a liver with ischemia-reperfusion injury. The marked hepatocyte has a non-apoptotic nucleus seen in blue, and has engulfed an apoptotic cell with a pink nucleus. 
Neighboring apoptotic hepatocytes can be seen with pink nuclei, and non-apoptotic cells with blue nuclei. The bars show 20 µm.
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etiologies,	 including	autoimmune,	metabolic,	viral,	and	genetic	
diseases	(12,	13).	The	rapid	processing	of	dead	and	dying	cells	is	
vital	to	moderate	inflammation	(12,	14,	15).
It	 is	 remarkable	 how	 little	 we	 know	 about	 the	 molecular	
mechanisms	that	govern	the	ability	of	the	largest	internal	organ	
in	the	body	to	mediate	the	clearance	of	damaged	or	dying	cells,	
given	that	 this	 is	one	of	 the	 liver’s	major	 functions.	Herein,	we	
bring	together	research	on	hepatocyte	efferocytosis	and	place	it	
into	context	with	current	molecular	knowledge	on	the	clearance	
of	dead	cells	by	immune	phagocytes.
CLeARANCe OF APOPTOTiC AND 
NeCROTiC CeLLS
Cells	die	through	a	wide	array	of	processes,	each	situational	and	
requiring	 their	own	dedicated	cascade	of	 signaling	events.	The	
most	frequent	forms	of	cell	death	are	attributed	to	apoptosis	or	
necrosis.	Apoptosis,	 an	 active	 form	of	programmed	cell	death,	
is	characterized	by	the	initiation	of	specific	inducible	pathways	
(16,	17).	This	includes	the	extrinsic	pathway;	the	engagement	of	
extracellular	signals,	including	Fas	ligand	(FasL)	(18)	and	tumor	
necrosis	 factor	 family	 cytokines	 (TNF)	 (19),	 amongst	 others,	
to	 their	 respective	 death	 receptors	which	 initiates	 intracellular	
death	 signaling.	 Apoptosis	 can	 also	 be	 triggered	 intrinsically;	
certain	 signals,	 such	 as	 a	 lack	 of	 growth	 factors,	 endoplasmic	
reticulum	stress	or	DNA	damage,	can	induce	a	shift	in	expression	
of	Bcl-2	family	mitochondrial	proteins	(20).	Increased	activity	of	
proapoptotic	proteins	lead	to	cytochrome	C	release	and	caspase	
9	activation.	Apoptosis	pathways	result	in	the	activation	of	effec-
tor	caspases	(3,	6,	and	7),	which	in	turn	begin	to	proteolytically	
degrade	 the	 cell’s	 components.	 Apoptotic	 cells	 are	 generally	
smaller	than	live	cells	and	can	be	identified	by	the	formation	of	
surface	blebs	(16).
Necrosis	 is	 considered	 a	 passive,	 unprogrammed	 type	 of	
cell	 death	 and	 is	 often	 incurred	 accidentally,	 although	 active	
mechanisms	 of	 necrosis	 have	 also	 been	 reported	 (21).	While	
multiple	 mechanisms	 can	 induce	 necrosis,	 the	 major	 causes	
are	 attributed	 to	 compromising	 of	 the	 plasma	 membrane,	 or	
depletion	 of	 energy	 (22).	 Furthermore,	 apoptotic	 cells	 can	 be	
converted	 to	necrotic	 cells	 (also	known	as	 secondary necrosis)	
if	ATP	 levels	 fall	 below	 the	quantity	 required	 to	 complete	 the	
active	apoptotic	process	(23).	The	appearance	of	necrotic	cells	is	
often	swollen	with	disrupted	organelle	and	plasma	membranes	
(24).	The	nucleus	 is	often	broken	down	and	will	be	unstained	
by	hematoxylin	(Figure 2).	As	necrosis	often	occurs	in	areas	of	
tissues,	rather	than	the	single	cell	death	hallmark	of	apoptosis,	
often	multiple	necrotic	cells	can	be	identified	in	one	area.	Due	
to	their	lack	of	integrity,	necrotic	cells	will	often	form	cell	debris,	
which	can	induce	liver	damage	if	not	cleared	swiftly,	as	we	dis-
cuss	in	later	sections.
Upon	the	death	of	a	cell,	its	corpse	must	be	cleared	through	
efferocytosis.	This	is	a	specialist	form	of	phagocytosis,	whereby	
fragments	of	 the	dying	 cells	 are	 engulfed	by	other	 cells,	which	
in	 turn	 degrade	 and	 recycle	 their	 components.	Although	 both	
apoptotic	 and	 necrotic	 cells	 are	 often	 captured	 by	 the	 same	
efferocytes,	 each	 are	 recognized	 through	 different	 means	 and	
yield	 differing	 response	 in	 the	 predatory	 cell	 (25).	 Apoptotic	
cells	are	most	commonly	recognized	through	the	display	of	the	
phospholipid	 phosphatidylserine	 (PtdSer)	 on	 the	 outer	 leaf	 of	
the	 plasma	membrane	 that	 can	 be	 recognized	 by	many	 recep-
tors	 [phosphatidylserine	 receptors	 (PSRs)]	 directly	 (26)	 or	 via	
association	with	low-density	lipoprotein	(27,	28).	Of	note,	in	a	rat	
FiguRe 3 | Visualizing efferocytosis by confocal microscopy. Hepatic epithelia were cocultured with violet-labeled staurosporin-treated apoptotic Jurkat T cells in 
the presence of pHrodo red, which only fluoresces in conditions of low pH (Thermo Fisher Scientific). CellMask Plasma Membrane stain was added to the culture 
media to label all exposed cell membranes before imaging. (A) Non-internalized apoptotic cells (blue) attached to hepatocytes were labeled by CellMask Plasma 
Membrane in white, and they were not labeled by pHrodo red dye (white arrow). (B) Internalized dead cells were not accessible to the membrane dye, confirming 
internalization (yellow arrow). Complete internalization into an acidic compartment was confirmed by pHrodo red, which detected efferosome acidification as early  
as 3 hours following engulfment. The scale bar indicates 5 µm.
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liver	model,	it	was	shown	that	recognition	of	apoptotic	cells	from	
mice	or	humans	was	reduced	compared	to	rat	cells;	it	is	therefore	
possible	that	species-specific	recognition	molecules	can	mediate	
efferocytosis	(29).
A	 phenotypic	 aspect	 of	 apoptotic	 cells	 is	 that,	 although	
shriveled,	the	cell	remains	intact	as	a	singular	body.	This	allows	
for	 a	 clean	 removal	 of	 the	 dying	 cells	 by	 efferocytes,	 usually	
without	 provoking	 an	 inflammatory	 response.	 How	 intact	
a	 necrotic	 cell	 remains	 is	 reflected	 through	 the	 manner	 in	
which	cell	death	was	induced.	As	such,	multiple	modalities	for	
necrotic	cell	recognition	are	necessary	to	guarantee	their	clear-
ance.	Some	reports	have	suggested	that	necrotic	cells	can	also	be	
recognized	by	PSRs	(30).	However,	due	to	the	lack	of	integrity	
of	most	necrotic	cells,	they	are	often	recognized	through	mol-
ecules	exposed	by	necrotic	death	(25).	The	same	mechanisms	
are	 also	 used	 to	 detect	 pathogens.	 For	 example,	 complement	
receptors	and	Fc	receptors	detect	opsonized	necrotic	cells,	and	
this	 recognition	 can	 trigger	 signaling	 events	 that	 activate	 the	
phagocyte	(31–35).	As	such,	necrotic	cells	are	engulfed	through	
the	 detection	 of	 autoantigens,	 which	 often	 increases	 the	 risk	
for	 autoimmune	disease.	Necrotic	 cells	 can	 also	 be	 indirectly	
recognized	through	opsonin	engagement	of	other	cellular	com-
ponents.	For	example,	ficolin-2	and	-3	have	been	shown	to	bind	
DNA,	facilitating	the	clearance	of	late-apoptotic/necrotic	cells	
through	 interactions	 with	 calreticulin	 (33,	 36).	 A	 ubiquitous	
mechanism	for	clearance	of	necrotic	cells	remains	uncertain.
The	differences	between	recognition,	and	thus	further	down-
stream	signaling	of	apoptotic	and	necrotic	cells,	result	in	conversing	
consequences	 for	 the	 efferocyte	 (37).	 Apoptotic	 cell	 clear-
ance	 generally	 leads	 to	 the	 production	 of	 anti-inflammatory	
stimuli	 and	 pro-resolution	 signals	 for	 inflammation	 such	 as	
interleukin	 10	 (IL-10)	 and	 TGF-β	 (38).	 Conversely,	 necrotic	
clearance	 generally	 results	 in	 pro-inflammatory	 signaling,	 as	
many	of	the	recognition	receptors	are	also	required	for	pathogen	
recognition.	In	the	liver,	the	signals	associated	with	hepatocyte	
death	were	recently	reviewed	by	Brenner	and	colleagues	(39).	
In	this	work	the	importance	of	the	extent	and	duration	of	dead	
cell	 accumulation	was	 highlighted,	 as	mild	 and	 localized	 cell	
death	can	aid	regeneration	and	exert	hepatoprotective	effects.	
Equally,	prolonged	and	wide-spread	cell	death	can	exacerbate	
liver	injury.
eXPeRiMeNTAL SYSTeMS TO STuDY 
eFFeROCYTOSiS
Multiple	 techniques	 have	 been	 described	 for	 both	 in  vivo	
and	 in  vitro	 studies	 of	 efferocytosis.	 Fluorescent	 dye-labeled	
efferocytes	 can	be	 “fed”	 alternatively	 labeled	dead	 cells	 under	
varying	 conditions	 and	 time	 courses.	 Early	 apoptosis	 can	 be	
confirmed	by	Annexin	V	labeling	of	the	cell	surface	as	it	binds	
directly	to	PtdSer,	although	care	must	be	taken	when	studying	
certain	activated	cell	types	or	using	calcium-sensitive	protocols	
(40).	Later	stages	of	apoptosis	or	necrosis	are	often	confirmed	
with	cell	 impermeable	DNA	dyes	such	as	7AAD	or	TOPRO-3	
iodide,	which	 can	 enter	 cells	 once	 the	membrane	 is	 compro-
mised.	Combined	 labeling	with	Annexin	V	and	a	membrane-
impermeable	DNA	 label	was	 developed	 to	 identify	 the	 stages	
of	apoptotic	cells	in	more	detail	(41).	Cells	can	then	be	assessed	
by	 flow	 cytometry,	 or	 imaged	 by	 fluorescent	 microscopy.	
Complete	internalization	of	dead	cells	can	be	confirmed	by	lack	
of	access	to	membrane	dyes	added	to	the	culture	media	(such	as	
CellMask	Plasma	Membrane	Stains,	Thermo	Fisher	Scientific)	
or	demonstration	of	efferosome	acidification	using	pH	indicator	
dyes	 (Figure  3).	Quantitative	 analyses	 by	 confocal	 and	 time-
lapse	microscopy	can	be	useful	to	determine	the	frequency	and	
kinetic	of	efferocytosis	in vitro.
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Fluorescent	 labeling	 of	 dead	 cells	 and	 efferocytes	 may	 also	
be	 adapted	 for	 flow	 cytometry-based	 studies,	whereby	double-
positive	cells	represent	efferocytes	containing	cargo.	This	form	of	
analysis	has	been	used	to	study	the	clearance	of	neuraminidase-
treated	red	blood	cells	in	mice	(42).	Other	studies	opt	to	analyze	
efferocytosis	using	downstream	secreted	molecules	as	proxy	 to	
utilize	alternative	techniques	such	as	reporter	assays.	The	capacity	
of	Scavenger	Receptor	Class	F	Member	1	(SCARF1)	to	act	as	a	
dead-cell	receptor	on	transfected	HEK293T cells,	for	example,	was	
confirmed	using	IL-8	mRNA	production	as	a	marker	of	NF-κB	
activation	following	apoptotic	and	necrotic	cell	efferocytosis	(43).
Efferocytosis	is	not	often	as	straightforward	to	detect	in vivo.	
Fluorescent	 labeling	 can	 enable	 temporal	 measurements	 in	
mouse	models	 by	 intravital	 imaging	 of	 the	 liver	 (44),	 but	 the	
technique	remains	to	be	adapted	successfully	for	use	in	human	
tissues	ex vivo.	Molecular	markers	of	cell	death	for	use	with	fixed	
tissue	are	often	important	for	the	confirmation	of	efferocytosis.	
Caspase	 3/7	 activation	 or	 their	 effects	 can	 be	 measured	 to	
delineate	apoptotic	bodies	by	immunohistochemistry	(IHC)	or	
immunofluorescence	(IF)	(45).	DNA	end-labeling	is	frequently	
used	 to	 confirm	 the	 death	 of	 cells	 in	 tissues.	 End-labeling	
involves	 the	 addition	 of	 labeled	 nucleotides	 to	 DNA	 breaks	
induced	throughout	multiple	modalities	of	death,	using	a	DNA	
polymerase.	This	was	historically	used	 for	 in  situ	 end	 labeling	
(ISEL)	of	fixed	tissue	sections	as	part	of	IHC	chromagen	stain-
ing	(Figure 2D)	(46).	This	was	then	adapted	for	the	creation	of	
terminal	 deoxynucleotidyl	 transferase	 (TdT)	 dUTP	 Nick-End	
Labeling	(TUNEL)	(47)	which	substitutes	a	polymerase	for	TdT.	
This	 adaptation	 allows	 for	 the	use	 of	many	different	modified	
forms	of	labeled	nucleotides	(often	dUTP),	such	as	non-reactive	
protein	tags	or	fluorophores.	TUNEL	staining	has	been	altered	
to	specifically	identify	cells	in	late-stage	apoptosis.
Further	stains	 for	cell	membrane	proteins	or	specific	nucleic	
proteins	can	be	used	to	determine	complete	engulfment	of	dead	
cells.	Many	of	these	techniques	were	exemplified	in	a	recent	study	
of	macrophage/monocyte	 efferocytosis	 in	models	 of	 acute	 liver	
injury	(48).	In	this	work,	Antoniades	and	colleagues	studied	the	
mechanism	of	resolution	of	liver	inflammation	through	apoptotic	
cell	clearance	by	macrophages/monocytes	via	Mer	tyrosine	kinase	
receptor	(MerTK).	Staining	for	myeloperoxidase	(activated	neu-
trophils)	 combined	with	 TUNEL	 allowed	 for	 the	 identification	
of	apoptotic	neutrophils	 in	human	liver,	both	through	IHC	and	
IF	staining.	Additionally,	fluorescent	monocytes	were	cocultured	
in  vitro	 with	 alternatively	 fluorescent	 apoptotic	 hepatic	 cells	 or	
neutrophils.	 The	 ability	 of	 these	 monocytes	 to	 clear	 apoptotic	
cells	was	then	assessed	through	fluorescent	microscopy	and	flow	
cytometry.	 Both	 techniques	 were	 used	 to	 show	 the	 increased	
capacity	of	monocytes	for	dead	cell	clearance	following	stimula-
tion	with	secretory	leukocyte	protease	inhibitor.
THe MeCHANiSM OF DeAD CeLL 
CAPTuRe BY PROFeSSiONAL AND  
NON-PROFeSSiONAL eFFeROCYTeS
Phagocytes	 express	 several	 receptors	 to	 recognize	 and	 sub-
sequently	 clear	 dying	 cells	 from	 the	 tissues	 (49–51).	 In	 the	
case	 of	 professional	 phagocytes	 (e.g.,	 macrophages)	 multiple	
apoptotic	 and	 necrotic	 cell	 receptors	 have	 been	 character-
ized	 and	 these	 remain	 relevant	 in	 the	 liver	 (37,	 52)	 (Table  1).	
First	described	in	1992,	it	is	now	widely	accepted	that	apoptotic	
cells	 are	 recognized	 through	 their	 expression	 of	 PtdSer	 on	 the	
outer	 leaf	 of	 the	 plasma	membrane	 (53,	 54).	 Several	 receptors	
directly	recognize	PtdSer,	many	of	which	are	expressed	by	profes-
sional	phagocytes	(55).	These	include	stabilin-1,	stabilin-2,	brain-
specific	angiogenesis	inhibitor	1	(BAI1),	and	RAGE,	as	well	as	the	
TIM	family	of	 transmembrane	glycoproteins,	 including	TIM-1,	
-3,	and	-4	(56–61).	Mammary,	alveolar	and	mesangial	epithelia	
recognize	 apoptotic	 cells	 via	 the	 PSR,	 CD36,	 the	 vitronectin	
receptor	αvβ3,	and	CD91	(62–64).	Of	note,	molecules	that	bind	
PtdSer	 such	 as	 high-mobility	 group	 box	 1	 (HMGB1)	 can	 also	
downregulate	apoptotic	cell	clearance	(65,	66).
It	 is	 common	 for	 PtdSer	 to	 be	 recognized	 in	 complex	with	
certain	bridging	molecules.	Some	of	the	most	well-studied	PtdSer	
receptors,	 the	TAM	 tyrosine	 kinases	 (Tyro3,	Axl,	 and	MerTK)	
work	in	this	manner	(102);	notably,	hepatocytes	express	Axl	but	
not	Tyro3	or	MerTK	(103).	The	earliest	known	examples	of	these	
are	Gas6	and	Protein	S	(104,	105).	Gas6	is	universally	recognized	
by	 TAM	 receptors,	 whereas	 Protein	 S,	 which	 is	 expressed	 in	
hepatocytes,	 is	not	recognized	by	Axl.	Similarly,	 integrins	αvβ3	
and	αvβ5	have	been	shown	to	promote	efferocytosis	through	the	
recognition	of	PtdSer	in	complex	with	lactadherin,	also	known	as	
milk	fat	globule	EGF	factor	8	(MFG-E8)	(67,	68,	106).
The	entirety	of	apoptotic	cell	recognition	does	not	lie	with	the	
detection	of	PtdSer	expression.	It	was	shown	that	Tubby	protein	
and	 its	 relative	 Tubby-like	 protein	 1	 (TuLP1),	 which	 do	 not	
bind	PtdSer,	specifically	localize	at	the	surface	of	apoptotic	cells	
and	could	act	as	TAM	receptor	bridging	molecules	in	a	similar	
manner	 to	Gas6,	which	 in	 turn	promoted	 apoptotic	 cell	 clear-
ance	(89).	All	TAM	tyrosine	kinases	recognized	TuLP1,	whereas	
Tubby	 was	 exclusively	 recognized	 by	MerTK	 on	macrophages	
and	retinal	pigment	cells.	Mechanisms	of	 immune	surveillance	
and	 signaling	have	also	been	 shown	 to	 contribute	 to	apoptotic	
cell	 clearance.	 Components	 of	 the	 complement	 pathway	 have	
been	shown	to	induce	phagocytosis	in	macrophages	and	DCs	by	
opsonizing	apoptotic	cells,	including	C1q	and	C3	(34,	78,	107).	
Furthermore,	 SIGN-R1,	 a	 mouse	 analog	 of	 human	 mannose	
receptor	DC-SIGN,	was	shown	to	bind	apoptotic	cells	and	induce	
their	labeling	with	C3	and	subsequent	clearance	by	marginal	zone	
macrophages	(92).
Recognition	 of	 apoptotic	 cells,	 although	 important,	 is	 not	
sufficient	for	macrophages	to	engulf	and	clear	them.	Downstream	
intracellular	signaling	is	necessary	for	 load-processing	follow-
ing	capture.	An	important,	highly-conserved	signaling	pathway	
has	 been	 described	 downstream	 from	most	 common	PtdSer-
receptors,	involving	GTPase	Rac1	and	ELMO1-DOCK180	inter-
actions	(50).	TAM-family	molecules,	αvβ5	integrins	and	BAI1	act	
as	docks	for	apoptotic	cells,	leading	to	intracellular	signaling	via	
this	pathway	(108,	109).	Upon	engagement	of	an	apoptotic	cell	
by	these	receptors,	DOCK180	is	recruited	by	ELMO1	(110,	111).	
In	 complex,	 these	 proteins	 act	 as	 guanine	 exchange	 factors,	
allowing	for	Rac1	activation,	which	induces	necessary	cytoskel-
etal	 arrangements	 required	 for	 complete	 engulfment	 of	 the	
prey	cell.	Stabilin	1	and	2	have	also	been	shown	to	activate	this	
TABLe 1 | Efferocytosis receptors in professional phagocytes and tissue epithelia.
Name Cell type Target Reference
Professional phagocyte receptors (macrophages/dendritic cells)
αvβ3 integrins Macrophages Lactadherin (MFG-E8)—PtdSer, vitronectin (67–69)
αvβ5 integrins Macrophages Lactadherin (MFG-E8)—PtdSer, vitronectin (67, 69–72)
Dendritic cells
Axl Monocytes/macrophages Gas6-PtdSer, Tubby-like protein 1 (GULP),  
Protein S
(73–76)
BAI1 (brain-specific angiogenesis inhibitor 1) Macrophages PtdSer (77)
Calrecticulin/CD91 Monocytes, macrophages, neutrophils Complement component C1q (34)
CD11/b/c/CD18 Monocytes, macrophages, neutrophils,  
human DCs
Complement component C3bi (78, 79)
CD14 Macrophages Phospholipids (not PtdSer-dependent) (80, 81)
CD36 Macrophages Thrombospondin + PtdSer + oxLDLs (82–84)
Clec9a Dendritic cells Necrotic cells, exposed actin filaments (85, 86)
LOX1 Macrophages oxLDLs—PtdSer (28, 87)
MARCO Macrophages Uncertain (88)
MerTK Monocytes/macrophages Gas6-PtdSer, Tubby, Protein S, Tubby-like  
protein 1, Protein S
(75, 89, 90)
Phosphatidylserine receptor (PSR) Monocytes/macrophages PtdSer (91)
RAGE (receptor for advanced glycation end 
products)
Alveolar macrophages PtdSer (60)
SCARF1 Monocytes and dendritic cells Complement component C1q—PtdSer (43)
Scavenger receptor A (SR-A) Macrophages Uncertain (88)
SIGN-R1 (specific intercellular adhesion molecule- 
3-grabbing nonintegrin-related 1) (murine)
Mouse marginal zone macrophages Not confirmed for apoptotic cells (92)
Stabilin-1 (CLEVER-1) Tissue-specific, alternatively activated 
macrophages
PtdSer (61)
Stabilin-2 Macrophages PtdSer (57)
TIM-3 (T cell/transmembrane, immunoglobulin,  
and mucin 3)
Dendritic cells PtdSer (93)
TIM-4 Monocytes/macrophages PtdSer (94)
Tyro3 (sky) Monocytes/macrophages Gas6-PtdSer, Protein S, Tubby-like protein 1, 
Protein S
(73–76)
Non-professional phagocytes
αvβ5 integrins Retinal epithelial cells Lactadherin (MFG-E8)-PtdSer (95)
ASGPR (asialoglycoprotein receptor) Hepatocytes asialoglycoprotein (96, 97)
CD36 Retinal Pigment cells PtdSer (98)
KIM-1 (kidney injury molecule 1)/TIM1 T cell/
transmembrane, immunoglobulin, and mucin 1
Injured kidney endothelial cells PtdSer (99)
LOX1 Endothelial cells oxLDLs—PtdSer. Ca2+-dependent (28, 100)
MerTK Retinal pigment cells Gas6-PtdSer, Tubby, Protein S, Tubby-like protein (89, 90)
Phosphatidylserine receptor (PSR) Fibroblasts PtdSer (91)
Epithelial cells
T and B lymphocytes (ectopic expression)
SCARF-1 (SREC-1) Endothelial cells Complement component C1q—PtdSer (43)
Stabilin-1 (Clever-1) Human sinusoidal endothelial cells PtdSer (101)
Stabilin-2 Human sinusoidal endothelial cells PtdSer (101)
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pathway	 through	 the	 adaptor	 protein	 GULP	 (109,	 112,	 113).	
Completion	 of	 apoptotic	 cell	 engulfment	 also	 commonly	
invol	ves	the	activation	of	nuclear	receptors.	Loose	nucleotides	
released	 from	 dying	 cells	 commonly	 act	 as	 “eat-me”	 signals,	
and	 can	 engage	 purigenic	 P2	 receptors	 (P2X	 and	P2Y),	 lead-
ing	 to	 an	 increased	 capacity	 for	 efferocytosis	 in	macrophages	
(114,	115).	 It	was	 recently	 shown	 that	 liver	X	 receptor	 (LXR)	
was	necessary	for	the	capture	and	processing	of	apoptotic	cells	
by	macrophages	and	dendritic	cells	 (116,	117).	LXR	responds	
to	 oxysterols	 found	 in	 engulfed	 apoptotic	 cells.	 Stimulation	
of	 LXR	 upregulated	MerTK	 and	 anti-inflammatory	 cytokines	
IL-10	and	TGF-β,	while	also	leading	to	the	downregulation	of	
proinflammatory	cytokines	such	as	IL-1β,	CCL2,	and	MARCO.	
A-Gonzalez	and	Hidalgo	reviewed	nuclear	receptors	and	their	
role	 in	macrophage	 efferocytosis	 recently	 (118).	 LXRα	medi-
ates	 fatty	 acid	 regulation	 in	 hepatocytes	 (119),	 but	 its	 role	 in	
hepatocyte	efferocytosis	remains	to	be	determined.
Non-professional	phagocytes,	such	as	epithelial	cells	express	
multifunctional	 scavenger	 receptors,	 or	 molecules	 that	 exert	
alternative	 functions	 in	 other	 cell	 types.	 For	 example,	 TIM-1,	
also	known	as	kidney	injury	molecule	1	(KIM-1),	 is	known	to	
possess	multiple	immune	functions,	including	CD4+	T-cell	and	
mast	cell	activation	(59).	However,	TIM-1	was	also	upregulated	
in	 kidney	 epithelia	 following	 injury,	 allowing	 for	 a	 temporary	
efferocytic	capability	 (99).	Certain	cell-exclusive	receptors	and	
modulators	 associated	 with	 apoptotic	 cell	 clearance	 have	 also	
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been	described.	Apoptotic	 cell	 clearance	 in	 the	 liver	 has	 been	
shown	 to	 involve	 asialoglycoprotein	 receptor	 (ASGPR)	 on	
hepatocytes	(96).	This	ASGPR1	and	ASGPR2	complex	is	critical	
for	receptor-mediated	endocytosis	of	terminally	desialylated	gly-
coproteins	and	is	restricted	to	the	liver.	Autoantibodies	to	ASGPR	
have	been	found	in	patients	and	models	of	autoimmune	hepatitis	
(120–122).	 Resolvin	 D1	 is	 also	 important	 in	 liver	 protection	
from	ischemia/reperfusion	injury,	by	enhancing	efferocytosis	by	
M2-polarizing	macrophages	 (123).	 Furthermore,	 phagocytosis	
by	 retinal	 pigment	 cells,	 although	 mostly	 conducted	 through	
MerTK,	 was	 shown	 to	 be	 increased	 through	 recognition	 of	
ATP-binding	cassette	subfamily	F	member	1	(ABCF1)	released	
from	 apoptotic	 photoreceptor	 outer	 segments	 (124).	 Overall,	
it	appears	that	although	the	broad	function	of	recognition	and	
engulfment	of	apoptotic	cells	is	conserved	throughout	many	cell	
types,	multiple	mechanisms	exist	 that	conduct	 these	processes	
across	phagocytes,	both	homo-	and	heterotypically.
ReguLATiON OF eFFeROCYTOSiS
External	stimuli	are	pertinent	for	regulation	of	dead	cell	clear-
ance	 by	 efferocytosis.	 As	 such,	 “find-me”	 signals	 released	 by	
apoptotic	cells	are	often	necessary	for	the	guidance	of	efferocytes	
to	their	prey	(53).	The	best-characterized	examples	of	these	are	
extracellular	nucleotides	(115).	It	was	shown	that	upon	caspase	
3/7	 activation	 in	 apoptotic	 cells,	ATP	 and	UTP	 released	 from	
apoptotic	 cells	 could	 recruit	monocytes/macrophages	 through	
recognition	 by	P2Y2.	Conversely,	molecules	with	 the	 opposite	
effect	known	as	“don’t eat-me”	signals	have	also	been	described.	
CD47	is	the	most	notable,	having	been	shown	to	provide	resist-
ance	to	clearance	by	macrophages	on	malignant	cells	and	more	
recently	 on	 atherosclerotic	 plaques	 (125,	 126).	 Similar	 “find-
me”	 signals	may	be	utilized	by	non-motile	 phagocytes,	which	
extend	protrusions	to	collect	apoptotic	cells	for	clearance	but	are	
restricted	to	targets	within	their	tissue	niche.
Due	to	the	influence	of	dying	cells	on	the	immune	response,	
cytokine	 and	 growth	 factor	 stimulation	 of	 both	 professional	
and	non-professional	phagocytes	 can	 regulate	 their	 capacity	 to	
clear	 dead	 cells.	 Apoptotic	 T-cell	 lymphomas	 release	 sphingo-
sine-1-phosphate,	 a	 bioactive	 lipid	 often	 involved	 in	 immune	
cell	recruitment,	leading	to	the	recruitment	of	macrophages	and	
monocytes	 (127).	 Similarly,	 certain	 chemokines,	 tasked	 with	
immune	cell	recruitment	have	also	been	shown	to	increase	phago-
cyte	recruitment	to	areas	of	apoptotic	cells.	CX3CL1	(fractalkine)	
was	shown	to	recruit	macrophages	to	its	source,	apoptotic	Burkitt	
lymphoma	cells	(128).
Multiple	cytokines	have	varying	effects	on	efferocytosis	(129).	
Most	notably,	secretion	of	IL-3	and	IL-14	increased	efferocytosis	
in	 macrophages	 through	 activation	 of	 PPAR	 and	 increase	 in	
CD36	expression	(130,	131).	IL-4	has	been	reported	to	upregulate	
expression	of	other	PtdSer-receptors	such	as	stabilin	1and	2	(61).	
IL-10	and	TGF-β	can	also	 increase	efferocytes	by	macrophages	
(132,	 133).	 In	 contrast,	 pro-inflammatory	 cytokines	 reduce	
the	 capacity	 for	 dead	 cell	 engulfment:	TNF-α	 has	 been	 shown	
to	 inhibit	 efferocytosis	 in	macrophages	 (134)	 and	 both	 IFN-γ	
secretion	and	receptiveness	were	reversely	correlated	with	anti-
inflammatory	cytokines	and	receptors	 including	 IL-4	and	TIM	
receptors	(59,	129,	135).	However,	 this	was	not	always	the	case	
for	these	cytokines.	Both	TNF-α	and	IFN-γ	have	been	shown	to	
increase	 LOX-1,	which	may	 recognize	 apoptotic	 cells	 by	 LDL-
labeled	PtdSer.	Furthermore,	 IFN-γ	activation	of	macrophages,	
in	the	absence	of	other	pro-inflammatory	stimuli,	was	shown	to	
increase	apoptotic	uptake	(135).
The	 ability	 of	 phagocytes	 to	 clear	 dead	 cells	 is	 also	 subject	
to	 regulation.	This	 is	 the	 result	 of	 alterations	 in	 gene	 expres-
sion,	which	 can	 function	 as	negative	 feedback	 following	 initial	
engulfment	of	dying	cells.	For	example,	 it	has	been	shown	that	
macrophages,	upon	engulfing	apoptotic	cells	can	undergo	a	form	
of	 activation	 and	 reprograming	 (136).	 As	 well	 as	 skewing	 the	
macrophage	 to	 a	more	 anti-inflammatory	phenotype,	which	 in	
turn	promotes	inflammatory	resolution,	both	mouse	and	human	
macrophages	can	upregulate	CXCR4	during	efferocytosis,	which	
in	 turn	 encourages	 their	 recruitment	 to	 draining	 lymph	nodes	
(137).	These	macrophages	were	also	shown	to	subsequently	reduce	
their	efferocytosis	capacity.	Thus,	apoptotic	cells	can	reduce	local	
levels	of	efferocytosis	as	well	as	promote	them.
More	 recently	 macrophages	 were	 shown	 to	 regulate	 effero-
cytosis	 in	 surrounding	 non-circulating	 phagocytes,	 such	 as	
pha	go	cytic	airway	epithelial	cells	(138).	In	response	to	IL-4	and	
IL-13,	which	 are	 secreted	by	 epithelia	 and	 stimulated	Th2	cells,	
macrophages	 upregulated	 secretion	 of	 both	 insulin-like	 growth	
factor	1	(IGF-1)	and	microvesicles	containing	anti-inflammatory	
signals.	Both	microvesicles	 and	 IGF-1,	 in	 turn,	 fed	back	 to	 epi-
thelia,	causing	a	reduction	of	apoptotic	cell	clearance	in	favor	of	
microvesicle	uptake.
In	the	context	of	the	liver,	some	of	the	mechanisms	described	
for	 the	 regulation	 of	 efferocytosis	 apply	 to	 circulating	 and	
resident	macrophages/monocytes.	 Further,	 the	 neuronal	 guid-
ance	protein	netrin-1	has	been	shown	to	promote	resolution	of	
ischemia/reperfusion	injury,	in	part	by	increasing	the	capacity	of	
Kupffer	cells	to	engulf	apoptotic	cells	(139).	The	same	molecule	
was	 shown	 to	 promote	 liver	 regeneration	 (139).	 In	 a	 mouse	
model	of	 colon	 carcinoma	metastasis	 in	 the	 liver,	 intercellular	
cell	 adhesion	 molecule	 1-deficient	 macrophages	 cocultured	
with	 tumor	cells	 showed	 increased	efferocytosis	dependent	on	
phosphatidylinositol	3	kinase	(140).
Environmental	 factors	 can	 also	 affect	 phagocytosis,	 and	
this	extends	to	the	clearance	of	dead	cells;	studies	 in	human	
skin	 have	 demonstrated	 that	 ethanol	 can	 reduce	 phagocytic	
function	 (141),	 and	 there	 have	 been	 reports	 on	 increased	
phagocytosis	 in	 ethanol-fed	 rats,	 which	 was	 modulated	 by	
diet	 (142).	 Hepatocyte	 phagocytosis	 of	 apoptotic	 cells	 was	
decreased	in	ethanol-fed	rats	compared	to	controls,	therefore	
the	 effects	 of	 ethanol	 on	 efferocytosis	 may	 be	 cell	 type-
dependent	(97).	It	is	unclear	whether	professional	phagocytes	
play	a	role	in	the	regulation	of	efferocytosis	by	hepatocytes	and	
liver	endothelial	cells.
THe iMPACT OF eFFeROCYTOSiS  
BY TiSSue ePiTHeLiA
Non-professional	efferocytes	are	important	throughout	all	devel-
opmental	stages	of	an	organism	and	can	take	over	the	clearance	
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of	 apoptotic	 cells	 in	 the	 absence	 of	 professional	 phagocytes	
(143).	 This	 was	 confirmed	 in	 PU.1	 knockout	 mice	 that	 lack	
macrophages,	 and	 the	 removal	 of	 apoptotic	 cells	 required	 for	
foot-limb	development	was	instead	performed	by	mesenchymal	
cells	(144).	Non-professional	phagocytes	therefore	contribute	to	
efferocytosis,	even	at	the	earliest	stages	of	development.
Some	of	the	best-studied	phagocytic	epithelia	are	bronchial	
and	 alveolar	 epithelial	 cells	 (138,	 145,	 146).	 Epithelial	 cells	
lining	 the	 respiratory	 tract	make	 first	 contact	 with	 airborne	
allergens	such	as	house	dust	mite	antigens.	Subsequent	inflam-
matory	stimuli,	 including	 the	recruitment	of	basophils,	mast	
cells	 and	 lymphocytes,	 result	 in	 epithelial	 cell	 injury.	 Lung	
epithelia	 clear	 their	 dying	 neighbors	 through	 PtdSer	 and	
Rac1-dependent	mechanisms,	which	can	be	modified	experi-
mentally	(146).	As	with	macrophages,	apoptotic	cell	clearance	
by	 lung	 epithelia	 induced	 anti-inflammatory	 cytokines	 such	
as	IL-10	and	TGF-β.	Conditional	Rac1	deletion	in	mouse	lung	
epithelia	 resulted	 in	 an	 exacerbated	 immune	 response	 and	
greater	 epithelial	 damage.	 These	 studies	 demonstrated	 the	
efficiency	and	importance	for	lung	epithelial	cell	efferocytosis	
in	the	regulation	of	lung	inflammation	(146,	147).
Retinal	epithelial	cell	efferocytosis	has	also	been	well	charac-
terized	(148–151).	Light-sensing	cells	of	the	retina	are	frequently	
turned	 over	 via	 programmed-cell	 death,	 often	 succumbing	 to	
autophagy-associated	 death,	 called	 autolysis	 (152,	 153).	 Dys-
regulation	of	autophagy	in	these	cells	has	been	frequently	reported	
to	 increase	 retinal	 pigment	 cell	 death	 (152,	 154).	 Although	 a	
normal	part	of	age-related	macular	degeneration,	failure	to	clear	
these	 dying	 cells	 can	 accelerate	 retinal	 damage.	 Together	 with	
professional	 phagocytes,	 retinal	 pigment	 cells	 are	 also	 charged	
with	the	removal	of	dead	cells,	in	a	manner	dependent	on	MerTK.
Throughout	the	lifecycle	of	an	organism,	the	removal	of	imma-
ture	 cells	 or	 those	with	high	 turnover	 is	necessary	 to	maintain	
tissue	homeostasis.	Intravital	microscopy	has	revealed	how	hair	
follicles	in	mice	regress	through	programmed	cell	death	of	hair-
producing	 basal	 epithelial	 cells	 (155).	 Neighboring	 cells	 of	 the	
same	type	then	clear	apoptotic	cells	through	mechanisms	requir-
ing	TGF-β	signaling.	In	response	to	kidney	damage,	epithelial	cells	
recognize	 and	engulf	PtdSer-positive	 apoptotic	 cells	via	KIM-1	
or	TIM-1	(99).	Colonic	epithelial	cells	have	also	been	shown	to	
engulf	their	apoptotic	neighbors,	which	aids	in	maintaining	low	
levels	of	inflammation	(156).
Studies	in	multiple	progenitor	types	have	recently	identified	
their	 importance	 in	 efferocytosis.	 Skeletal	muscle	 progenitors	
recognizing	PtdSer	on	neighboring	apoptotic	cells,	receive	the	
signal	 to	 differentiate	 and	 fuse	 into	 multinuclear	 myofibers	
(157).	Mesenchymal	stem	cells	take	their	cues	from	bone	mar-
row	 apoptotic	 cells	 via	 efferocytosis	 and	 undergo	 osteogenic	
differentiation	 (158).	 Chondrogenic	 progenitor	 cells	 display	
macrophage-like	abilities	in	that	they	react	to	“find-me”	signals	
from	apoptotic	 cells	 (159),	 and	non-motile	 chondrocytes	 also	
have	a	role	in	efferocytosis	(160).	As	previously	discussed,	neu-
ronal	progenitors	which	apoptose	following	failure	to	complete	
neural	circuits	 throughout	neurogenesis,	were	recognized	and	
cleared	by	other	progenitor	cells	via	Rac1	activation	following	
ELMO-1	signaling	(161).	Of	note,	neuronal	and	hepatic	epithe-
lia	can	be	derived	from	common	progenitor	cells.
Through	its	cardinal	role	 in	the	neutralization	of	 toxic	sub-
stances,	 to	 its	 frequent	 influx	 and	 arresting	 of	 leukocytes,	 the	
liver	has	evolved	to	cope	well	with	cell	death	(10,	162).	Although	
hepatocytes	 are	 somewhat	 resistant	 to	 intrinsic	 apoptotic	
pathways	 (163–165),	 many	 death	 receptors	 are	 ubiquitously	
expressed	throughout	the	liver,	increasing	their	susceptibility	to	
extrinsic	apoptosis	by	exposure	to	pro-inflammatory	cytokines	
such	as	TNF	family	molecules	including	TNF-related	apoptosis-
inducing	 ligand	 (TRAIL)	 (166–170).	 Clearance	 of	 apoptotic	
cells	 by	 macrophages	 is	 a	 pro-resolution	 process,	 however,	
liver-infiltrating	macrophages	and	Kupffer	cells	can	upregulate	
death	 ligands	 in	 the	 liver,	 including	FasL,	TNF-α,	 and	TRAIL,	
increasing	the	rate	of	local	hepatocyte	death	and	the	risk	of	fur-
ther	inflammation	(171,	172).	Acute	injury	such	as	ischemia	and	
the	resulting	trauma	from	hypoxia/reoxygenation	can	also	result	
in	similar	sudden	increases	in	necrotic	cell	death	(164,	165,	169).	
Furthermore,	steatosis—accumulation	of	lipids	associated	with	a	
multitude	of	fatty	liver	diseases—can	cause	wide	hepatocyte	cell	
death	via	lipoapoptosis	induced	by	ER	stress-mediated	intrinsic	
pathways	 (173,	174).	Ethanol-induced	 injury	 can	 also	have	 an	
impact	 on	 receptor-mediated	 endocytosis	 by	 the	 ASGPR	 and	
efferocytosis	(175–178).
Failure	to	clear	dead	cells	from	the	parenchyma	is	accumula-
tively	detrimental	to	the	liver;	clearance	of	necrotic	cells—both	
primary	 and	 secondary,	 resulting	 from	 uncleared	 apoptotic	
cells—results	 in	 increase	 in	 pro-inflammatory	 cell	 influx	 and	
cytokine	 secretion,	 leading	 to	 further	 damage	 to	 the	 liver	
(14).	 HMGB1	 is	 important	 in	 liver	 protection	 from	 ischemia/
reperfusion	 injury	 (179),	 yet	 in	 a	 sterile	 model	 it	 acted	 as	 a	
damage-associated	molecular	pattern	that	enhanced	liver	injury	
in	 both	 ischemia/reperfusion	 and	POD	models	 (180).	 Interac-
tions	bet	ween	ASGPR	on	hepatocytes	and	B220	epitope	of	CD45	
assist	 in	the	capture	and	trapping	of	apoptotic	cells	 in	the	 liver	
(96,	 181,	 182).	The	 impact	 of	 hepatocyte	 efferocytosis	 on	 the	
inflammatory	milieu	remains	to	be	established.
Beyond	the	capacity	of	hepatocytes	for	erythrocytosis	(183),	
further	 evidence	 or	 insights	 into	 the	 mechanisms	 or	 anti-
inflammatory	impact	of	hepatocyte	efferocytosis	have	not	been	
elucidated.	 Hepatocytes	 express	 an	 array	 of	 immunomodula-
tory	cytokines,	 including	TNF-α	and	IL-10	(184–186);	 it	 is	not	
known	whether	 these	are	modulated	during	efferocytosis	 as	 in	
lung	 epithelia	 and	 in	 professional	 phagocytes.	 Understanding	
the	molecular	mechanisms,	purpose	and	regulation	of	dead	cell	
clearance	 by	 hepatocytes	 is	 vital	 to	 estimate	 its	 impact	 on	 the	
onset	and	resolution	of	inflammation,	as	elevation	in	hepatocyte	
apoptosis	 is	 key	 to	 the	 pathogenesis	 and	 progression	 of	 most	
forms	of	liver	disease	(14).	Outstanding	questions	on	hepatocyte	
efferocytosis	include:
	–	 What are the molecules that mediate recognition and engulfment 
of apoptotic and/or necrotic cells by hepatocytes?	ASGPR	is	thus	
far	 the	 only	 receptor	 restricted	 to	 hepatocyte	 efferocytosis;	
despite	 its	multiple	roles	 in	receptor-mediated	efferocytosis,	
ASGPR-deficient	mice	develop	normally	yet	have	exacerbated	
pathology	in	liver	injury	models	(177,	187).
	–	 Is efferocytosis by hepatocytes in portal and centrilobular 
regions mediated by the same molecular mechanisms?	These	
TABLe 2 | The role of efferocytosis in liver diseases.
Liver disease efferocytosis relevance Reference
Autoimmune 
hepatitis
Hepatocyte stress and correlations to disease (39, 121, 
195)Autoantibodies targeting ASGPR
Primary biliary 
cholangitis
Phagocytes were shown to contain PDC-E2 
immunogen
(8, 196, 
199–201)
Biliary injury clearance is linked to autoimmunity
Biliary injury clearance alleviates liver fibrosis
Primary 
sclerosing 
cholangitis
Collection of genome-wide studies that show a 
role of apoptosis 
(202)
Alcohol injury Ethanol exacerbates injury in ASGPR-deficient 
model
(97, 177, 
178, 203, 
204)
Fatty liver 
diseases
The role of specialized proresolving mediators  
in obese individuals (enhance efferocytosis)
(205–207)
Other liver 
injuries
Alpha 1 antitrypsin rescues macrophage 
efferocytosis
(139, 196, 
208)
Netrin 1 rescues efferocytosis in murine I/R injury 
model
Efferocytosis and tissue remodeling in rat bile duct 
ligation model
Although efferocytosis is critical for liver homeostasis, there is limited information on 
specific efferocytosis pathways that contribute to liver disease pathogeneses. The 
importance of dead cell clearance is better established than the mechanisms that 
mediate efferocytosis in the inflamed or injured liver.
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regions	 have	 differential	 access	 to	 apoptotic	 and	 necrotic	
cells,	respectively,	as	well	as	nutrient,	inflammatory	infiltrate	
and	oxygenation	levels	that	may	all	influence	the	capacity	for	
efferocytosis.
	–	 How is hepatocyte efferocytosis regulated in health, infection, 
inflammation and cancer?
	–	 Can hepatocyte efferocytosis be modulated by pharmacological 
interventions?
	–	 Does efferocytosis affect the ability of hepatocytes to regenerate 
during injury?
CLiNiCAL iMPLiCATiONS OF DeFeCTS  
iN eFFeROCYTOSiS
Failure	to	remove	dying	cells,	both	apoptotic	and	necrotic,	have	
been	 connected	 to	 disease	 exacerbation	 (49).	Accumulation	 of	
dying	cells	increases	the	availability	of	proimmunogenic	factors	
and	can	increase	the	risk	of	autoimmunity,	especially	as	death-
recognition	 becomes	 skewed	 to	 proinflammatory	 recognition	
of	secondary-necrotic	cells.	This	topic	was	explored	in	a	recent	
special	issue	in	Frontiers	in	Immunology	(188).
Defects	in	efferocytosis	have	also	been	shown	to	be	beneficial	
for	 the	 longevity	of	 tumors.	Upregulation	 in	 the	“don’t-eat	me”	
signal	CD47	was	reported	in	myeloid	leukemia	(189,	190)	which	
was	associated	with	increased	tumor	survival	and	poorer	prog-
nosis.	Similar	pathogenic	consequences	of	aberrant	efferocytosis	
have	 been	 exemplified	 through	 deficiencies	 in	 death	 receptors	
(1).	Loss	of	axl,	MerTK,	and	its	associated	ligand,	Gas6,	have	all	
been	shown	to	promote	the	growth	of	colon	cancers	(191,	192).	
Conversely,	 loss	 of	 stabilin-1	 has	 shown	 to	 reduce	 growth	 of	
implanted	tumors	in	knockout	mice,	due	to	reduced	recruitment	
of	 tumor-associated	 lymphocytes	 and	 macrophages	 (193).	 As	
such,	 loss	of	death-receptor	 expression	 is	not	 always	beneficial	
for	 cancer	 vitality.	 However,	 loss	 of	 other	 receptors	 for	 dying	
cells	has	displayed	varying	phenotypes	associated	with	the	lack	
of	 apoptotic	 cell	 clearance.	 Loss	 of	 SCARF1	 and	 axl	 has	 been	
reported	to	promote	autoimmunity	(43,	194).
Similar	dangers	to	those	mentioned	above	regarding	deficien-
cies	in	dying	cell	clearance	are	apparent	for	many	liver	diseases.	In	
the	context	of	the	liver,	the	effects	of	efferocytosis	in	autoimmune	
family	disorders	have	not	been	established	directly.	Reports	on	
efferocytosis	in	liver	diseases	are	listed	in	Table 2.	Clearance	of	
dying	cells	 in	the	 liver	 is	 thought	to	reduce	the	risk	of	autoim-
mune	hepatitis	and	promote	reversal	of	fibrosis	by	macrophages	
(195,	196).	In	primary	biliary	cholangitis,	efferocytosis	by	biliary	
epithelia	may	be	 important	 in	defining	 the	 tissue	 specificity	of	
the	autoimmune	response	(8,	197).	It	 is	worth	considering	that	
standard	of	care	treatments	for	autoimmune	conditions	include	
corticosteroid	 regimens,	which	have	been	 shown	 to	upregulate	
efferocytosis	(49,	198).	Prevention	of	efferocytosis	may	therefore	
exacerbate	liver	diseases.
As	 well	 as	 causing	 hepatocyte	 necrosis,	 chronic	 alcohol	
exposure	 was	 reported	 to	 reduce	 macrophage	 efferocytosis	
through	 diminishing	MFG-E8	 expression	 (209).	 Prevention	 of	
efferocytosis	by	macrophages	in	the	liver	could	increase	further	
inflammatory	 stimuli,	 although	 it	 is	 not	 clear	 how	 hepatocyte	
efferocytosis	would	be	affected.	Contrarily,	reduced	efferocytosis	
in	certain	disease	models	has	been	shown	to	be	beneficial.	Loss	
of	the	dead-cell	receptor	TIM4,	for	example,	in	a	mouse	model	of	
ischemia/reperfusion	injury	reduced	immune	cell	infiltration	and	
hepatocyte	 damage	 (210).	 Understanding	 the	 protein-specific	
and	situational	benefits	or	detriments	to	reduced	efferocytosis	in	
diseases	of	the	liver	and	other	organs	can	give	insights	into	possible	
therapeutics	for	tissue	damage	and	autoimmunity.
CONCLuSiON
Recent	advances	in	epithelial	cell	efferocytosis	have	highlighted	
the	 importance	of	 tissue	 epithelia	 in	 the	 everyday	 clearance	of	
billions	of	apoptotic	cells.	Compared	to	professional	efferocytes,	
there	 is	 little	 known	 regarding	 the	 receptors	 and	 molecular	
processes	involved	in	the	recognition	of	apoptotic	and	necrotic	
cells	 by	 non-professional	 phagocytes,	 including	molecules	 that	
may	confer	tissue-specific	function.	Given	the	impact	of	effero-
cytosis	on	 the	pathogenesis	of	autoimmunity,	 tissue	 injury	and	
tumor	 biology	 (211),	 molecules	 driving	 efficient	 clearance	 of	
dead	cells	are	valid	therapeutic	targets.	Hepatocyte	efferocytosis,	
accomplished	at	least	in	part	by	the	liver-restricted	ASGPR,	is	an	
attractive	 target	 for	 therapeutic	 intervention	 for	a	multitude	of	
liver	diseases.
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